{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:49Z","timestamp":1786985089871,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.beha.2005.01.006","type":"journal-article","created":{"date-parts":[[2005,7,17]],"date-time":"2005-07-17T08:33:11Z","timestamp":1121589191000},"page":"525-536","source":"Crossref","is-referenced-by-count":14,"title":["Genetics of multiple myeloma"],"prefix":"10.1016","volume":"18","author":[{"given":"Michaela J.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.01.006_bib1","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood.V85.9.2490.bloodjournal8592490","article-title":"Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis [review] [41 refs]","volume":"85","author":"Lai","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis","volume":"66","author":"Dewald","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.V71.2.453.453","article-title":"Plasma cell karyotype in multiple myeloma","volume":"71","author":"Gould","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.1996.d01-2939.x","article-title":"Multiple-myeloma-almost all patients are cytogenetically abnormal","volume":"94","author":"Zandecki","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","article-title":"Cytogenetic findings in 200 patients with multiple myeloma","volume":"82","author":"Sawyer","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2005.01.006_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/sj.leu.2401041","article-title":"Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases","volume":"12","author":"Smadja","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2005.01.006_bib7","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","article-title":"Hypodiploidy is a major prognostic factor in multiple myeloma","volume":"98","author":"Smadja","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2402797","article-title":"Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma","volume":"17","author":"Debes-Marun","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2005.01.006_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-4608(99)00009-6","article-title":"Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma","volume":"113","author":"Rajkumar","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2005.01.006_bib10","first-page":"3607","article-title":"Primary plasma cell leukemia and multiple myeloma: one or two diseases according to the methodology [letter; comment]","volume":"94","author":"Smadja","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib11","first-page":"3854","article-title":"Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization","volume":"55","author":"Drach","year":"1995","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.beha.2005.01.006_bib12","first-page":"1558a","article-title":"Cytogenetic abnormalities in multiple myeloma and related plasma cell disorders; a comparison of conventional cytogenetic analysis to fluorescent in-situ hybridization with simultaneous cytoplasmic immunoglobulin staining (meeting abstract)","volume":"90","author":"Fonseca","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.1996.d01-2939.x","article-title":"Multiple myeloma: almost all patients are cytogenetically abnormal","volume":"94","author":"Zandecki","year":"1996","journal-title":"Br J Haematol."},{"key":"10.1016\/j.beha.2005.01.006_bib14","first-page":"153","article-title":"Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes","volume":"149","author":"Tabernero","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2005.01.006_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V59.1.43.43","article-title":"Ploidy and proliferative characteristics in monoclonal gammopathies","volume":"59","author":"Latreille","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-4608(94)90008-6","article-title":"Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study","volume":"74","author":"Zandecki","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2005.01.006_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.1995.tb05602.x","article-title":"Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells","volume":"90","author":"Zandecki","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib18","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.V90.9.3682","article-title":"Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition","volume":"90","author":"Zandecki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib19","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V86.10.3915.bloodjournal86103915","article-title":"Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance","volume":"86","author":"Drach","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib20","first-page":"144","article-title":"Clonal chromosomal aberrations in plasma cells from patients with monoclonal gammopathy of undetermined significance (MGUS) (Meeting abstract)","volume":"36","author":"Drach","year":"1995","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1016\/j.beha.2005.01.006_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.1998.01034.x","article-title":"Chromosomal abnormalities in systemic amyloidosis","volume":"103","author":"Fonseca","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib22","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2003-02-0493","article-title":"The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma","volume":"102","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/gcc.10275","article-title":"Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases","volume":"38","author":"Smadja","year":"2003","journal-title":"Genes, Chromosomes Cancer"},{"key":"10.1016\/j.beha.2005.01.006_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-4608(82)90017-6","article-title":"Prognostic implications of ploidy and proliferative activity in human solid tumors","volume":"6","author":"Barlogie","year":"1982","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2005.01.006_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428199909145707","article-title":"Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?","volume":"35","author":"Greipp","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2005.01.006_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cyto.990170409","article-title":"A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38\/propidium iodide double staining technique","volume":"17","author":"Orfao","year":"1994","journal-title":"Cytometry"},{"key":"10.1016\/j.beha.2005.01.006_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V55.3.403.403","article-title":"Cellular DNA content as a marker of human multiple myeloma","volume":"55","author":"Latreille","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib29","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","article-title":"Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes","volume":"91","author":"Perez-Simon","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0002-9343(86)90625-X","article-title":"Biclonal and hypodiploid multiple myeloma","volume":"80","author":"Smith","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.006_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2141.1997.2443061.x","article-title":"Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma","volume":"98","author":"Calasanz","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2141.2002.03757.x","article-title":"Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma","volume":"118","author":"Fassas","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib33","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2005.01.006_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s004320050011","article-title":"The biology of multiple myeloma [review] [64 refs]","volume":"126","author":"Drach","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.006_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib37","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib38","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood.V97.6.1566","article-title":"(IFM) obotIFdM. Chromosome 13 abnormalities identified by FISH analysis and serum beta-2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy","volume":"97","author":"Facon","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib39","first-page":"715","article-title":"Biologic and prognostic significance of interphase FISH detection of chromosome 13 abnormalities (\u039413) in multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) Study","volume":"62","author":"Fonseca","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2005.01.006_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.2001.02546.x","article-title":"Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma","volume":"112","author":"Sawyer","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib41","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1182\/blood.V92.11.4269","article-title":"Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping","volume":"92","author":"Sawyer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-4608(99)00144-2","article-title":"Multiple myeloma: monoallelic deletions of the tumor suppressor genes TP53 and RB1 in long-term follow-up","volume":"117","author":"Carlebach","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2005.01.006_bib43","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/sj.leu.2401909","article-title":"Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance","volume":"14","author":"Konigsberg","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2005.01.006_bib44","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome","volume":"94","author":"Avet-Loiseau","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib45","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.leu.2403518","article-title":"translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma","volume":"18","author":"Kaufmann","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2005.01.006_bib46","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1365-2141.2000.02488.x","article-title":"Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13","volume":"111","author":"Avet-Loiseau","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.leu.2402125","article-title":"Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q-arm or monosomy","volume":"15","author":"Fonseca","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2005.01.006_bib48","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"Shaughnessy","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib49","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","article-title":"Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities","volume":"95","author":"Desikan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2141.2003.03948.x","article-title":"Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II","volume":"120","author":"Shaughnessy","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib51","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1182\/blood-2002-09-2873","article-title":"Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with total therapy I: interpretation in the context of global gene expression","volume":"101","author":"Shaughnessy","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib52","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1997.15.7.2659","article-title":"Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants","volume":"15","author":"Tricot","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.006_bib53","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","article-title":"Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities","volume":"86","author":"Tricot","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.1998.00657.x","article-title":"Prognostic value of cytogenetics in multiple myeloma","volume":"101","author":"Seong","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib55","first-page":"223","article-title":"Translocations into IgH Switch Regions\u2014The Genetic Hallmark of Multiple Myeloma","volume":"86","author":"Bergsagel","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib56","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1073\/pnas.93.24.13931","article-title":"Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma","volume":"93","author":"Bergsagel","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2005.01.006_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-065X.2003.00052.x","article-title":"Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma","volume":"194","author":"Bergsagel","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beha.2005.01.006_bib58","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Intergroupe Francophone du M. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib59","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V90.2.526","article-title":"The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization","volume":"90","author":"Nishida","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib61","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","article-title":"Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy","volume":"100","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib62","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","article-title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","volume":"101","author":"Keats","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.beha.2005.01.006_bib64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V97.3.822","article-title":"Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique","volume":"97","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib65","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy","volume":"92","author":"Drach","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2141.1999.01615.x","article-title":"P53 deletion is not a frequent event in multiple myeloma [see comments]","volume":"106","author":"Avet-Loiseau","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.006_bib67","article-title":"P53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation","author":"Chang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib68","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V91.5.1732","article-title":"Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin","volume":"91","author":"Sawyer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9440(10)63276-2","article-title":"Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma","volume":"165","author":"Inoue","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2005.01.006_bib70","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib71","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","article-title":"Myeloma and the t(11;14)(q13;q32) represents a uniquely defined biological subset of patients","volume":"99","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib72","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood.V98.7.2266","article-title":"Translocations involving heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis","volume":"98","author":"Hayman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib73","unstructured":"Harrison, C, Mazullo, H, Cheung, K, Mehta, A, Lachmann, H, Hawkins, P, Orchard, K. Chromosomal abnormalities in systemic amyloidosis. Proceedings of the VIII International Myeloma Workshop. Banff, Alberta, Canada; 2001: P18."},{"key":"10.1016\/j.beha.2005.01.006_bib74","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1349-7006.2003.tb01445.x","article-title":"Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia","volume":"94","author":"Miura","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.beha.2005.01.006_bib75","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","article-title":"Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants","volume":"101","author":"Avet-Loiseau","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib76","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1309\/4W8E-8F4K-BHUP-UBE7","article-title":"The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study","volume":"113","author":"Hoyer","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2005.01.006_bib77","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2002-11-3333","article-title":"CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma","volume":"102","author":"Robillard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib78","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood-2002-12-3789","article-title":"Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation","volume":"102","author":"Soverini","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib79","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V98.4.1271","article-title":"The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathies of undetermined significance","volume":"98","author":"Fonseca","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2005.01.006_bib81","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025","article-title":"The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH\/MMSET hybrid transcripts","volume":"92","author":"Chesi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib82","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","article-title":"A novel chromosomal translocation t(4;14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene","volume":"90","author":"Richelda","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.006_bib83","first-page":"4058","article-title":"Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts","volume":"60","author":"Malgeri","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2005.01.006_bib84","first-page":"1599","article-title":"Translocation t(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis","volume":"158","author":"Perfetti","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2005.01.006_bib85","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1182\/blood-2002-09-2801","article-title":"A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH\/MMSET fusion transcript","volume":"101","author":"Santra","year":"2003","journal-title":"Blood"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:53:40Z","timestamp":1586318020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1521692605000083"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.01.006","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}